Exicure (XCUR) Enterprise Value (2016 - 2026)
Exicure (XCUR) reported Enterprise Value of -$2.6 million for Q1 2026, up 75.01% on a YoY basis from -$1.5 million in Q1 2025, and up 30.49% quarter-over-quarter from -$3.7 million in Q4 2025.
Exicure (XCUR) Enterprise Value (2016 - 2026) Analysis & Trends
Exicure has reported Enterprise Value for 11 years, with the latest figure at -$2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 75.01% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$2.6 million (up 75.01% YoY), and the FY2025 full-year result was -$3.7 million, up 70.05% from the prior year.
- Enterprise Value for Q1 2026 stood at -$2.6 million, up from -$3.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$343000.0 in Q3 2024, with the low at -$26.4 million in Q1 2022.
- Historically, Enterprise Value has averaged -$7.8 million across 5 years, with a median of -$4.4 million in 2025.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 96.33% — and 2025, when it tumbled 2746.99%.
- Exicure's Enterprise Value stood at -$9.8 million in 2022, then surged by 79.38% to -$2.0 million in 2023, then plunged by 520.44% to -$12.5 million in 2024, then soared by 70.05% to -$3.7 million in 2025, then soared by 30.49% to -$2.6 million in 2026.
- The last three Enterprise Value figures came in at -$2.6 million (Q1 2026), -$3.7 million (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -4.44 Mn |
| Jun 30, 2025 | -7.86 Mn |
| Mar 31, 2025 | -10.42 Mn |
| Dec 31, 2024 | -12.51 Mn |
| Sep 30, 2024 | -343,000.00 |
| Jun 30, 2024 | -528,000.00 |
| Mar 31, 2024 | -366,000.00 |
| Dec 31, 2023 | -2.02 Mn |
| Sep 30, 2023 | -922,000.00 |
| Jun 30, 2023 | -2.34 Mn |
| Mar 31, 2023 | -9.96 Mn |
| Dec 31, 2022 | -9.78 Mn |
| Sep 30, 2022 | -15.65 Mn |
| Jun 30, 2022 | -22.20 Mn |
| Mar 31, 2022 | -26.38 Mn |
| Dec 31, 2021 | -39.14 Mn |
| Sep 30, 2021 | -60.84 Mn |
| Jun 30, 2021 | -56.06 Mn |